Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
A deal could be reached as soon as Monday and could include additional payments tied to Kelonia meeting certain milestones, The Wall Street Journal reported.